alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › plasma-phospho-tau217

plasma-phospho-tau217

4 studies tagged plasma-phospho-tau217, dated 2024-02-08 to 2025-04-09. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Plasma phospho-tau217 for Alzheimer's disease diagnosis in primary and secondary care using a fully automated platform 2025-04-09
  2. Plasma phospho-tau217 as a predictive biomarker for Alzheimer's disease in a large south American cohort 2025-01-02
  3. PrecivityAD2™ Blood Test: Analytical Validation of an LC-MS/MS Assay for Quantifying Plasma Phospho-tau217 and Non-Phospho-tau217 Peptide Concentrations That Are Used with Plasma Amyloid-β42/40 in a Multianalyte Assay with Algorithmic Analysis for Detecting Brain Amyloid Pathology 2024-08-10

Studies

4 studies carry this tag.

Date range

2024 to 2025

Top journals

  • Alzheimer's research & therapy 2
  • Diagnostics (Basel, Switzerland) 1
  • Nature medicine 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Plasma phospho-tau217 for Alzheimer's disease diagnosis in primary and secondary care using a fully automated platform

    ✓ Peer-reviewed alzhub usefulness score 62 out of 100. Nature medicine 2025-04-09 Biomarkers

    Global implementation of blood tests for Alzheimer's disease (AD) would be facilitated by easily scalable, cost-effective and accurate tests.

  2. Plasma phospho-tau217 as a predictive biomarker for Alzheimer's disease in a large south American cohort

    ✓ Peer-reviewed alzhub usefulness score 62 out of 100. Alzheimer's research & therapy 2025-01-02 Biomarkers

    Most investigations have previously focused on highly selected cohorts with established AD-endophenotypes (CSF biomarkers, autopsy report, PET etc.), while data on cohorts with clinical assessment are currently lacking, especially in non-European populations.

  3. PrecivityAD2™ Blood Test: Analytical Validation of an LC-MS/MS Assay for Quantifying Plasma Phospho-tau217 and Non-Phospho-tau217 Peptide Concentrations That Are Used with Plasma Amyloid-β42/40 in a Multianalyte Assay with Algorithmic Analysis for Detecting Brain Amyloid Pathology

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Diagnostics (Basel, Switzerland) 2024-08-10 Biomarkers

    Alzheimer's disease (AD) is a progressive irreversible neurodegenerative disorder that represents a major global public health concern.

  4. Effects of certain pre-analytical factors on the performance of plasma phospho-tau217

    ✓ Peer-reviewed alzhub usefulness score 55 out of 100. Alzheimer's research & therapy 2024-02-08 Biomarkers

    Centrifugation improved the performance of plasma p-tau217, but thawing temperatures and up to three freeze-thaw cycles did not have a significant impact.

All topic tags with their study counts